TY - JOUR
T1 - Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin
AU - Gotto, Antonio
PY - 2005/9/5
Y1 - 2005/9/5
N2 - There are overwhelming data in favor of cholesterol as a modifiable risk factor for coronary artery disease (CAD). Lifestyle modifications are considered first-line treatments for lowering cholesterol, but drug therapies are recommended in at-risk groups. Trials published before the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III reports have helped statins emerge at the forefront of lipid therapies, and more recent trials have shed light on high-risk prevention. Although 6 statins are currently available, large clinical trials reported thus far have mainly evaluated atorvastatin, lovastatin, pravastatin, and simvastatin in the prevention of CAD and other cardiovascular events. A few small end point trials have evaluated fluvastatin, whereas rosuvastatin trials are only in their early days.
AB - There are overwhelming data in favor of cholesterol as a modifiable risk factor for coronary artery disease (CAD). Lifestyle modifications are considered first-line treatments for lowering cholesterol, but drug therapies are recommended in at-risk groups. Trials published before the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III reports have helped statins emerge at the forefront of lipid therapies, and more recent trials have shed light on high-risk prevention. Although 6 statins are currently available, large clinical trials reported thus far have mainly evaluated atorvastatin, lovastatin, pravastatin, and simvastatin in the prevention of CAD and other cardiovascular events. A few small end point trials have evaluated fluvastatin, whereas rosuvastatin trials are only in their early days.
UR - http://www.scopus.com/inward/record.url?scp=23944502862&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23944502862&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2005.06.010
DO - 10.1016/j.amjcard.2005.06.010
M3 - Article
C2 - 16126021
AN - SCOPUS:23944502862
VL - 96
SP - 34
EP - 38
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149
IS - 5 SUPPL.
ER -